• Publications
  • Influence
Epidemiology and costs of chronic obstructive pulmonary disease
SERIES “THE GLOBAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE” Edited by K.F. Rabe and J.B. Soriano Number 1 in this Series Chronic obstructive pulmonary disease (COPD) is a leadingExpand
  • 652
  • 18
The economic burden of COPD.
COPD is one of the leading causes of morbidity and mortality worldwide and imparts a substantial economic burden on individuals and society. Despite the intense interest in COPD among clinicians andExpand
  • 377
  • 15
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
BackgroundStatins are a class of medications that reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Whether statins can benefit patients with dementia remains unclearExpand
  • 320
  • 15
Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty.
Post-Operative Cognitive Decline (POCD) is a complication of Coronary Artery Bypass Graft (CABG) surgery and is consistent with reduced neuronal reserve. We performed a retrospective cohort analysisExpand
  • 144
  • 10
The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design.
Quantifying COPD prevalence worldwide is needed to document COPD's effect on disability, health care costs, and impaired quality of life and to inform governments and health planners. As an adjunctExpand
  • 257
  • 9
  • PDF
Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM).
OBJECTIVE To develop a multi-attribute outcome measure for children with asthma that allows for the calculation of quality-adjusted life years in cost-effectiveness studies and can also be used toExpand
  • 53
  • 8
  • PDF
Use of a preference-based measure of health (EQ-5D) in COPD and asthma.
BACKGROUND EQ-5D is a generic preference-based measure of health that can help to understand the impact of asthma and chronic obstructive pulmonary disease (COPD). The purpose of this paper was toExpand
  • 119
  • 8
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008
BackgroundTreatment of chronic diseases such as chronic obstructive pulmonary disease (COPD) is complicated by the presence of comorbidities. The objective of this analysis was to estimate theExpand
  • 188
  • 7
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease
BackgroundAdministrative data is often used to identify patients with chronic obstructive pulmonary disease (COPD), yet the validity of this approach is unclear. We sought to develop a predictiveExpand
  • 93
  • 7
Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease
Context Many think we need more information about the safety of respiratory medications for chronic obstructive pulmonary disease (COPD). Contribution This large casecontrol study examinedExpand
  • 177
  • 6
  • PDF